CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 66.67%

Compliant submissions 2

Incompliant submissions 1

Total trials 3

My Organizations' Clinical Trials

Showing 225 of 1308 entries

View as:

Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)

Phase: N/A Priority: Normal

NCT ID: NCT01052428 Org: User:

Start: 08/31/04 End: 07/31/10 Due: 07/31/11

A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)

Phase: N/A Priority: Normal

NCT ID: NCT06173323 Org: User:

Start: 09/16/24 End: 01/31/28 Due: 01/31/29

The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain

Phase: N/A Priority: Normal

NCT ID: NCT00885976 Org: User:

Start: 09/30/11 End: 02/29/12 Due: 02/28/13

Comparison of Sacral Interface Pressure in Healthy Volunteers on Two Dynamic Pressure-Prevention Support Surfaces

Phase: N/A Priority: Normal

NCT ID: NCT06661954 Org: User:

Start: 10/11/24 End: 10/23/24 Due: 10/23/25

Dissemination and Implementation of Stroke Prevention Looking at the Care Environment

Phase: N/A Priority: Normal

NCT ID: NCT04173026 Org: User:

Start: 06/04/20 End: 06/30/23 Due: 06/30/24

Novel Methods for Ascertainment of Gout Flares -A Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT02855437 Org: User:

Start: 09/30/16 End: 08/31/18 Due: 08/31/19

Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor

Phase: N/A Priority: Normal

NCT ID: NCT00004159 Org: User:

Start: 02/29/00 End: 02/29/00 Due: 02/28/01

miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome

Phase: N/A Priority: Normal

NCT ID: NCT02418195 Org: User:

Start: 04/20/15 End: 12/30/20 Due: 12/30/21

Glaucoma Management Optimism for African Americans Living With Glaucoma

Phase: N/A Priority: Normal

NCT ID: NCT03159481 Org: User:

Start: 07/13/18 End: 12/31/22 Due: 12/31/23

Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta

Phase: N/A Priority: Normal

NCT ID: NCT03713710 Org: User:

Start: 11/28/16 End: 12/31/19 Due: 12/31/20

Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT02133313 Org: User:

Start: 05/31/14 End: 03/31/17 Due: 03/31/18

Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia

Phase: N/A Priority: Normal

NCT ID: NCT00584129 Org: User:

Start: 02/28/06 End: 12/31/14 Due: 12/31/15

The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00657358 Org: User:

Start: 04/30/08 End: 01/31/12 Due: 01/31/13

The Alabama NSAIDs Patient Safety Survey, Phase II: Reducing Disparities in Risk Awareness and Communication

Phase: N/A Priority: Normal

NCT ID: NCT01352832 Org: User:

Start: 05/31/11 End: 03/31/12 Due: 03/31/13

Speed of Processing Training in Adults With HIV

Phase: N/A Priority: Normal

NCT ID: NCT02758093 Org: User:

Start: 09/28/16 End: 03/11/20 Due: 03/11/21

Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD

Phase: N/A Priority: Normal

NCT ID: NCT06169852 Org: User:

Start: 01/12/24 End: 12/01/29 Due: 12/01/30

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

Phase: N/A Priority: Normal

NCT ID: NCT05414500 Org: User:

Start: 05/01/23 End: 07/31/26 Due: 07/31/27

Obesity and Endogenous Oxalate Synthesis

Phase: N/A Priority: Normal

NCT ID: NCT03808090 Org: User:

Start: 01/01/13 End: 07/31/24 Due: 07/31/25

Comparison of Three Opioid Detoxification Treatment Regimens

Phase: N/A Priority: Normal

NCT ID: NCT03678792 Org: User:

Start: 11/15/19 End: 10/25/20 Due: 10/25/21

Skeletal Health in Bariatric Surgery Patients

Phase: N/A Priority: Normal

NCT ID: NCT03331536 Org: User:

Start: 03/22/18 End: 08/02/20 Due: 08/02/21

Improving Gout Care After an ED Visit

Phase: N/A Priority: Normal

NCT ID: NCT06534554 Org: User:

Start: 06/18/24 End: 06/01/26 Due: 06/01/27

Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty

Phase: N/A Priority: Normal

NCT ID: NCT03408483 Org: User:

Start: 04/01/18 End: 08/22/20 Due: 08/22/21

The Bottle Study: Infant Weight Gain During Use of Novel Versus Typical Infant Feeding Bottles

Phase: N/A Priority: Normal

NCT ID: NCT01526018 Org: User:

Start: 01/31/12 End: 01/31/14 Due: 01/31/15

Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3

Phase: N/A Priority: Normal

NCT ID: NCT03333174 Org: User:

Start: 04/09/18 End: 07/01/21 Due: 07/01/22

Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation

Phase: N/A Priority: Normal

NCT ID: NCT03103100 Org: User:

Start: 10/08/15 End: 09/09/19 Due: 09/09/20

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)	NCT01052428	University of Alabama at Birmingham	user2@example.com	None	2004-08-31	2010-07-31	2011-07-31	-	-	2025-07-14
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)	NCT06173323	University of Alabama at Birmingham	user2@example.com	None	2024-09-16	2028-01-31	2029-01-31	-	-	2025-07-14
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain	NCT00885976	University of Alabama at Birmingham	user2@example.com	None	2011-09-30	2012-02-29	2013-02-28	-	-	2025-07-14
Comparison of Sacral Interface Pressure in Healthy Volunteers on Two Dynamic Pressure-Prevention Support Surfaces	NCT06661954	University of Alabama at Birmingham	user2@example.com	None	2024-10-11	2024-10-23	2025-10-23	-	-	2025-07-14
Dissemination and Implementation of Stroke Prevention Looking at the Care Environment	NCT04173026	University of Alabama at Birmingham	user2@example.com	None	2020-06-04	2023-06-30	2024-06-30	-	-	2025-07-14
Novel Methods for Ascertainment of Gout Flares -A Pilot Study	NCT02855437	University of Alabama at Birmingham	user2@example.com	None	2016-09-30	2018-08-31	2019-08-31	-	-	2025-07-14
Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor	NCT00004159	University of Alabama at Birmingham	user2@example.com	None	2000-02-29	2000-02-29	2001-02-28	-	-	2025-07-14
miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome	NCT02418195	University of Alabama at Birmingham	user2@example.com	None	2015-04-20	2020-12-30	2021-12-30	-	-	2025-07-14
Glaucoma Management Optimism for African Americans Living With Glaucoma	NCT03159481	University of Alabama at Birmingham	user2@example.com	None	2018-07-13	2022-12-31	2023-12-31	-	-	2025-07-14
Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta	NCT03713710	University of Alabama at Birmingham	user2@example.com	None	2016-11-28	2019-12-31	2020-12-31	-	-	2025-07-14
Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis	NCT02133313	University of Alabama at Birmingham	user2@example.com	None	2014-05-31	2017-03-31	2018-03-31	-	-	2025-07-14
Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia	NCT00584129	University of Alabama at Birmingham	user2@example.com	None	2006-02-28	2014-12-31	2015-12-31	-	-	2025-07-14
The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers	NCT00657358	University of Alabama at Birmingham	user2@example.com	None	2008-04-30	2012-01-31	2013-01-31	-	-	2025-07-14
The Alabama NSAIDs Patient Safety Survey, Phase II: Reducing Disparities in Risk Awareness and Communication	NCT01352832	University of Alabama at Birmingham	user2@example.com	None	2011-05-31	2012-03-31	2013-03-31	-	-	2025-07-14
Speed of Processing Training in Adults With HIV	NCT02758093	University of Alabama at Birmingham	user2@example.com	None	2016-09-28	2020-03-11	2021-03-11	-	-	2025-07-14
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD	NCT06169852	University of Alabama at Birmingham	user2@example.com	None	2024-01-12	2029-12-01	2030-12-01	-	-	2025-07-14
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides	NCT05414500	University of Alabama at Birmingham	user2@example.com	None	2023-05-01	2026-07-31	2027-07-31	-	-	2025-07-14
Obesity and Endogenous Oxalate Synthesis	NCT03808090	University of Alabama at Birmingham	user2@example.com	None	2013-01-01	2024-07-31	2025-07-31	-	-	2025-07-14
Comparison of Three Opioid Detoxification Treatment Regimens	NCT03678792	University of Alabama at Birmingham	user2@example.com	None	2019-11-15	2020-10-25	2021-10-25	-	-	2025-07-14
Skeletal Health in Bariatric Surgery Patients	NCT03331536	University of Alabama at Birmingham	user2@example.com	None	2018-03-22	2020-08-02	2021-08-02	-	-	2025-07-14
Improving Gout Care After an ED Visit	NCT06534554	University of Alabama at Birmingham	user2@example.com	None	2024-06-18	2026-06-01	2027-06-01	-	-	2025-07-14
Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty	NCT03408483	University of Alabama at Birmingham	user2@example.com	None	2018-04-01	2020-08-22	2021-08-22	-	-	2025-07-14
The Bottle Study: Infant Weight Gain During Use of Novel Versus Typical Infant Feeding Bottles	NCT01526018	University of Alabama at Birmingham	user2@example.com	None	2012-01-31	2014-01-31	2015-01-31	-	-	2025-07-14
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3	NCT03333174	University of Alabama at Birmingham	user2@example.com	None	2018-04-09	2021-07-01	2022-07-01	-	-	2025-07-14
Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation	NCT03103100	University of Alabama at Birmingham	user2@example.com	None	2015-10-08	2019-09-09	2020-09-09	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance